JP2013500256A5 - - Google Patents

Download PDF

Info

Publication number
JP2013500256A5
JP2013500256A5 JP2012521761A JP2012521761A JP2013500256A5 JP 2013500256 A5 JP2013500256 A5 JP 2013500256A5 JP 2012521761 A JP2012521761 A JP 2012521761A JP 2012521761 A JP2012521761 A JP 2012521761A JP 2013500256 A5 JP2013500256 A5 JP 2013500256A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
poly
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012521761A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013500256A (ja
JP5837491B2 (ja
Filing date
Publication date
Priority claimed from US12/558,395 external-priority patent/US8173666B2/en
Application filed filed Critical
Priority claimed from PCT/US2010/042792 external-priority patent/WO2011011543A1/en
Publication of JP2013500256A publication Critical patent/JP2013500256A/ja
Publication of JP2013500256A5 publication Critical patent/JP2013500256A5/ja
Application granted granted Critical
Publication of JP5837491B2 publication Critical patent/JP5837491B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012521761A 2009-07-21 2010-07-21 オリゴマー−オピオイドアゴニスト抱合体 Expired - Fee Related JP5837491B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22739909P 2009-07-21 2009-07-21
US61/227,399 2009-07-21
US12/558,395 2009-09-11
US12/558,395 US8173666B2 (en) 2007-03-12 2009-09-11 Oligomer-opioid agonist conjugates
US35085310P 2010-06-02 2010-06-02
US61/350,853 2010-06-02
PCT/US2010/042792 WO2011011543A1 (en) 2009-07-21 2010-07-21 Oligomer-opioid agonist conjugates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015139389A Division JP2015180698A (ja) 2009-07-21 2015-07-13 オリゴマー−オピオイドアゴニスト抱合体

Publications (3)

Publication Number Publication Date
JP2013500256A JP2013500256A (ja) 2013-01-07
JP2013500256A5 true JP2013500256A5 (OSRAM) 2013-09-05
JP5837491B2 JP5837491B2 (ja) 2015-12-24

Family

ID=43499405

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012521761A Expired - Fee Related JP5837491B2 (ja) 2009-07-21 2010-07-21 オリゴマー−オピオイドアゴニスト抱合体
JP2015139389A Pending JP2015180698A (ja) 2009-07-21 2015-07-13 オリゴマー−オピオイドアゴニスト抱合体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015139389A Pending JP2015180698A (ja) 2009-07-21 2015-07-13 オリゴマー−オピオイドアゴニスト抱合体

Country Status (9)

Country Link
EP (2) EP2456469A1 (OSRAM)
JP (2) JP5837491B2 (OSRAM)
KR (1) KR101788886B1 (OSRAM)
CN (1) CN102573918A (OSRAM)
AU (1) AU2010276244B2 (OSRAM)
CA (1) CA2768392C (OSRAM)
IL (3) IL217634B (OSRAM)
MX (1) MX2012000980A (OSRAM)
WO (1) WO2011011543A1 (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
PL2621496T5 (pl) 2010-09-30 2019-05-31 Astrazeneca Ab Krystaliczny koniugat naloksol-peg
WO2013070617A1 (en) 2011-11-07 2013-05-16 Nektar Therapeutics Compositions, dosage forms, and coadministration of an opioid agonist compound and an analgesic compound
US10525054B2 (en) 2011-11-07 2020-01-07 Inheris Biopharma, Inc. Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound
WO2014070745A1 (en) * 2012-10-30 2014-05-08 Nektar Therapeutics Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof
ITRM20130223A1 (it) * 2013-04-15 2014-10-16 Rosario Nicoletti Derivati della codeina come inibitori della glucuronazione della morfina
CA2919892C (en) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN107019803B (zh) * 2016-01-29 2020-09-15 北京键凯科技股份有限公司 具有低成瘾作用的聚乙二醇化阿片样物质
CN107033154B (zh) 2016-02-02 2020-02-04 上海瀚迈生物医药科技有限公司 阿片受体拮抗剂缀合物及其应用
CN111936549B (zh) * 2018-03-29 2023-03-10 日油株式会社 包含三苯甲基的单分散聚乙二醇的纯化方法
CN111039764A (zh) * 2018-10-12 2020-04-21 山东大学 一种双亲乙烯衍生物及制备方法
WO2021029914A1 (en) * 2019-08-11 2021-02-18 Kappa-Pharma LLC Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates
CN116925105B (zh) * 2022-04-11 2025-11-25 上海瀚迈生物医药科技有限公司 阿片受体拮抗剂缀合物的固体盐型、晶型及其制备方法、组合物和用途
CN117567477A (zh) * 2023-11-15 2024-02-20 宜昌人福药业有限责任公司 一种氢吗啡酮和二氢吗啡类药物低分子聚乙二醇化物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628962A (en) 1949-10-20 1953-02-17 Mallinckrodt Chemical Works Method for preparing dihydrocodeinone, dihydromorphinone, and codeinone
US2654756A (en) 1949-10-20 1953-10-06 Mallinckrodt Chemical Works Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
US2649454A (en) 1951-08-20 1953-08-18 Univ California Method for preparing dihydromorphinone, dihydrocodeinone, and dihydropseudocodeinone
US2806033A (en) 1955-08-03 1957-09-10 Lewenstein Morphine derivative
AU6044496A (en) * 1995-06-05 1996-12-24 Cortech, Inc. Compounds having bradykinin antagonistic activity and mu-opi oid agonistic activity
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
EP1782834A3 (en) * 2003-03-13 2007-08-01 Controlled Chemicals, Inc. Oxycodone conjugates with lower abuse potential and extended duration of action
RS53279B (sr) 2003-12-16 2014-08-29 Nektar Therapeutics Monodisperzne smeše pegilisanog naloksola
ME02176B (me) * 2007-03-12 2015-10-20 Nektar Therapeutics Konjugati oligomerno-opioidnog agonista
KR101660996B1 (ko) * 2008-09-16 2016-09-28 넥타르 테라퓨틱스 남용에 대한 낮은 잠재성을 갖는 페길화 오피오이드

Similar Documents

Publication Publication Date Title
JP2013500256A5 (OSRAM)
JP2014515406A5 (OSRAM)
JP2012522898A5 (OSRAM)
JP2008525416A5 (OSRAM)
JP2009519243A5 (OSRAM)
JP2009541289A5 (OSRAM)
JP2011523643A5 (OSRAM)
JP2005532287A5 (OSRAM)
JP2019512492A5 (OSRAM)
JP2013507423A5 (OSRAM)
MX2010003950A (es) Derivado de amina que tiene actividad antagonista del receptor y5 de neuropeptido y (npy) y uso del mismo.
JP2013503846A5 (OSRAM)
JP2011511075A5 (OSRAM)
JO2644B1 (en) Derivatives of N- (amino-aryl mixture) -H1- indole-2-carboxamide Synthesis and therapeutic use
JP2008510828A5 (OSRAM)
JP2012502904A5 (OSRAM)
JP2012515219A5 (OSRAM)
JP2006514626A5 (OSRAM)
CY1117067T1 (el) Η χρηση σωματιδιων στερεων φορεων για τη βελτιωση της επεξεργασιμοτητας φαρμακευτικου παραγοντα
JP2009535358A5 (OSRAM)
JP2012513416A5 (OSRAM)
JP2009530392A5 (OSRAM)
JP2010501478A5 (OSRAM)
JP2012531508A5 (OSRAM)
ATE482221T1 (de) Bisamid-zinkbasen